Trial intelligence / Profile preview

Injectable naltrexone for alcohol dependence

NCT00000442Phase 4Completed

Sponsor
UConn Health
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of naltrexone in alcohol dependence, sponsored by UConn Health. Status: completed.

02

Drugs

naltrexone
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00000442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call